Three-Statement Breakdown
REVENUE DOWN
Revenue fell 5.5% year over year to $4.0B, and carried a 7.6% net margin.
REVENUE
-5.5%
4,017
GROSS PROFIT
—
—
NET INCOME
-6.7%
305
EPS (DILUTED)
-6.2%
$0.76
| Income statement | 24-09 | 24-12 | 25-03 | 25-06 | 25-09 | 25-12 | 26-03 | QoQ | YoY | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 6,288 | 4,037 | 3,933 | 4,250 | 4,971 | 4,584 | 5,640 | 4,017 | -28.8% | -5.5% | |
| SG&A | (411) | (464) | (391) | (419) | (444) | (460) | (427) | (392) | -8.2% | -6.4% | |
| Operating income | 2,588 | 599 | -120 | 515 | 1,037 | 474 | 1,499 | 553 | -63.1% | +7.4% | |
| Interest expense | (332) | (157) | (319) | (303) | (286) | (271) | (263) | (312) | +18.6% | +3.0% | |
| Income tax | (555) | -39 | -176 | (76) | (204) | (75) | (183) | (122) | -33.3% | +60.5% | |
| Net income | 1,888 | 441 | -268 | 327 | 652 | 233 | 1,029 | 305 | -70.4% | -6.7% | |
| EPS (diluted) |
NOT DISCLOSED
10-Q
|
$5.25 | — | -$0.93 | $0.81 | $1.75 | — | $2.87 | $0.76 | -73.5% | -6.2% |
Click a line to select it — Enter or the EXPAND pill folds out its quarter-by-quarter history.
No comparable bridge for this view yet.
↹ CLICK A LINE TO SELECT · ⌘F FIND LINE ITEM
SRC 10-Q FILED 2026-08-10 ↗